Octapharma AB (manufacturer responsible for manufacturing in bulk, primary packaging, visual inspection, integrity testing, quality testing, batch release of the final product (powder for solution for injection and solvent))

Ukraine

All drugs from this manufacturer

  • NUVIK / NUWIQ®

    It is used for the treatment and prevention of bleeding in patients with hemophilia A (a disease caused by a deficiency of clotting factor VIII).

    Dosage form: powder and solvent for injection solution

    Active substance Dosage
    simoctocog alfa 500 IU

    ATC: B02BD02

  • NUVIK / NUWIQ®

    It is used for the treatment and prevention of bleeding in patients with hemophilia A (a disease caused by a deficiency of clotting factor VIII).

    Dosage form: powder and solvent for injection solution

    Active substance Dosage
    simoctocog alfa 1000 IU

    ATC: B02BD02

  • NUVIK / NUWIQ®

    It is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital deficiency of clotting factor VIII).

    Dosage form: powder and solvent for injection solution

    Active substance Dosage
    simoctocog alfa 1500 IU

    ATC: B02BD02

  • NUVIK / NUWIQ®

    It is used for the treatment and prevention of bleeding in patients with hemophilia A (a disease caused by a deficiency of clotting factor VIII).

    Dosage form: powder and solvent for injection solution

    Active substance Dosage
    simoctocog alfa 2500 IU

    ATC: B02BD02

  • NUWIK / NUWIQ®

    It is used for the treatment and prevention of bleeding in patients with hemophilia A (a disease caused by a deficiency of clotting factor VIII).

    Dosage form: powder and solvent for injection solution

    Active substance Dosage
    simoctocog alfa 250 IU

    ATC: B02BD02

  • NUWIK / NUWIQ®

    It is used for the treatment and prevention of bleeding in patients with hemophilia A (a disease caused by a deficiency of clotting factor VIII).

    Dosage form: powder and solvent for injection solution

    Active substance Dosage
    simoctocog alfa 2000 IU

    ATC: B02BD02

  • NUWIK / NUWIQ®

    It is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital deficiency of coagulation factor VIII).

    Dosage form: powder and solvent for injection solution

    Active substance Dosage
    simoctocog alfa 3000 IU

    ATC: B02BD02

  • NUWIK / NUWIQ®

    It is used for the treatment and prevention of bleeding in patients with hemophilia A (a disease caused by a deficiency of clotting factor VIII).

    Dosage form: powder and solvent for injection solution

    Active substance Dosage
    simoctocog alfa 4000 IU

    ATC: B02BD02